CClinicalTrials.gg
RecruitingNCT07434583Updated Feb 25, 2026

Force Sensor Study

An interventional study of Direct laryngoscopy force modulation and Direct laryngoscopy without force modulation in Laryngeal Disease, Post-operative Pain and Tongue Injury, sponsored by University of California, San Francisco. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-25.

Sponsored by University of California, San Francisco · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Jan 2026; still recruiting 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This research is to understand more about the forces that are involved on the tongue and other oropharyngeal structures during laryngeal surgery. This information will be used to determine if these forces can affect outcomes (pain, numbness, taste, etc) and whether factors such as procedure type, surgeon experience (i.e. resident, fellow, attending), and choice of surgical equipment affect these forces. This information may be used to reduce these forces and prevent these issues from happening during certain laryngeal surgeries.

For the first 50 patients, force measurements will be taken and correlated to outcome measures . Surgeons will be blinded to the force measurements intra-operatively.

For the next 50 patients, surgeons will be given force measurements in real-time intra-operatively allowing adjustments to be made. The impact of this adjustment on outcomes will be determined.

02

Conditions studied

  • Laryngeal Disease
  • Post-operative Pain
  • Tongue Injury
03

In context

Laryngeal Diseases

136 studies on the registry are indexed under Laryngeal Diseases; 23 are open to participants now.

This study's planned enrollment of 100 is above the median of 41 across 111 interventional studies indexed under Laryngeal Diseases.

Browse Laryngeal Diseases studies →

Lead sponsor

University of California, San Francisco is the lead sponsor of 2,132 studies on the registry; 375 are open to participants now.

Of its 262 completed or terminated interventional studies of FDA-regulated products, 196 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • >18 years old with
  • undergoing laryngeal surgery with direct laryngoscopy

Exclusion criteria

Exclusion Criteria:

  • Prior history of tongue dysfunction such as glossectomy (hemi or total) or hypoglossal nerve injury
  • Patient inability to follow up after initial procedure
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Active comparator
    Surgeon blinded

    Patients will undergo direct laryngoscopy with force measurements taken intra-operatively. Post-operative outcome measures will be collected.

    Procedure: Direct laryngoscopy without force modulation

  • Experimental
    Surgeon unblinded

    Patients will undergo direct laryngoscopy with force measurements taken intra-operatively. The surgeon will be aware of force measurements in real-time, allowing for adjustments to reduce applied force during direct laryngoscopy. Post-operative outcome measures will be collected.

    Procedure: Direct laryngoscopy force modulation

Interventions

  • ProcedureDirect laryngoscopy force modulation

    Modification of applied force during direct laryngoscopy using real-time force sensor measurements.

  • ProcedureDirect laryngoscopy without force modulation

    Patients will undergo direct laryngoscopy as is done in standard of care without active modulation of applied force

06

What researchers measure

Primary outcomes

  1. Short Form McGill Pain Questionnaire (SF-MPQ)

    The SF-MPQ includes the following components: 15 descriptors: * 11 sensory, each rated 0=none, 1=mild, 2=moderate, 3=severe * 4 affective , each rated 0=none, 1=mild, 2=moderate, 3=severe. A Present Pain Intensity (PPI) scale (0=No Pain, 1=Mild, 2=Discomforting, 3=Distressing, 4=Horrible, 5=Excruciating) Visual Analogue Scale of average pain (VAS, 0-10 cm) - higher score is worse pain

    Time frame: 1 day, 14 days, and 1 month post-operatively

Secondary outcomes

  1. Tongue mobility

    Assessment of changes in tongue mobility post-operatively. My physician report Tongue deviation is: 0 - absent 1 - present

    Time frame: 1 month post-operatively

  2. Tongue sensation

    Assessment of changes in tongue sensation post-operatively, according to patient report: My tongue numbness is: 0 - absent 1. \- minimal 2. \- mild 3. \- moderatre 4. \- severe

    Time frame: 1 day, 14 days, and 1 month post-operatively

  3. Change in taste

    Assessment of changes in taste post-operatively, according to patient report: My tongue numbness is: 0 - absent 1 - minimal 2 - mild 3 - moderatre 4 - severe

    Time frame: 1 day, 14 days, 1 month post-operatively

07

Study locations

1 of 1 sites recruiting
  • University of California San Francisco
    San Francisco, California 94115, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07434583
Lead sponsor
University of California, San Francisco
Responsible party
Sponsor
First posted
Feb 25, 2026
Start date
Jan 2, 2026
Primary completion
Jan 31, 2027 (estimated)
Completion
Jan 31, 2027 (estimated)
Last update
Feb 25, 2026

Study contacts

Riley Jackson
Contact
riley.jackson@ucsf.edu
6282526882
Tyler Crosby, MD
principal investigator · University of California, San Francisco

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion